Share of branded drug costs in Medicare Part D gap in the U.S. 2016-2020
Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020
This statistic displays the projected distribution of cost-sharing for brand name drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020. In 2016, five percent of the cost of brand name drugs is expected to be paid by CMS. Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies.
Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020
Loading statistic...
| Paid by enrollee | Paid by CMS | Manufacturer discount | |
|---|---|---|---|
| 2016 | 45% | 5% | 50% |
| 2017 | 40% | 10% | 50% |
| 2018 | 35% | 15% | 50% |
| 2019 | 30% | 20% | 50% |
| 2020 | 25% | 25% | 50% |
Source
More information
Statistics on "Medicare"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Medicare's costliest drugs 2015
- Medicare hospital inpatient charges by disease in the U.S. 2016
- Medicare hospital inpatient case charges by severity in the U.S. 2014
- Name-brand versus store brand: U.S. consumers' purchase preferences of OTC drugs 2014
- Italy: sales volume percentage change of leading brand name drugs 2018
- Leading ten Medicare Advantage organizations by enrollment 2017
- Enrollment of Medicare Advantage by plan type 2011-2017
- Percentage of Medicare Advantage plans by plan type 2018
- Medicare Advantage enrollment in top ten states in the U.S. 2017
- Enrollment of Medicare Advantage within Medicare 2004-2017
- Penetration of Medicare Advantage into Medicare 2004-2017
- Hospital stays with leading operating room procedure paid by Medicare 2012
- Medicare - number of general hospital facilities in the U.S. 1967-2014
- Share of hospitals penalized by Medicare for high readmission rates U.S. 2013-2017
- Rates of Medicare acceptance in select U.S. metropolitan areas by specialty 2013
- Brand name influence on sports footwear purchase decisions in the United States 2014
- Opinions on the extent of EU control over drug policy in the Netherlands 2019
- Brand name influence on sports apparel purchase decisions in the United States 2014
- Net favorability of denim brands in the United States in 2018
Statistics on "Medicare"
Related topics
About Statista
